Completed PHASE2 INTERVENTIONAL 1-arm NCT02660177

Pharmacokinetics of Intravenous Metamizole in Children Less Than 6 Years Old (PPMS)

Single Center, Open-label, Prospective Study to Characterize the Pharmacokinetics of Metamizole and Its Metabolites Following Intravenous Administration in Children Less Than 6 Years Old

Sponsor: University Children's Hospital Basel

Conditions Children Pain Surgery

Interventions Metamizole

Updated 5 times since 2017 Last updated: May 28, 2018 Started: Apr 30, 2016 Primary completion: Dec 31, 2017 Completion: Dec 31, 2017

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT02660177, this PHASE2 trial focuses on Children and Pain and remains completed. Sponsored by University Children's Hospital Basel, it has been updated 5 times since 2016, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2
Jan 2021 — Jul 2024 [monthly]

Completed PHASE2
Jun 2018 — Jan 2021 [monthly]

Completed PHASE2

Status: Recruiting → Completed
Jan 2017 — Jun 2018 [monthly]

Recruiting PHASE2

First recorded

Apr 2016

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

University Children's Hospital Basel

Data source: University Children's Hospital Basel

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Basel, Switzerland